Victoria Serra - Laboratorio Reig Ma HR
| RJF Stock | EUR 2.76 0.02 0.72% |
Insider
Victoria Serra is Ma HR of Laboratorio Reig Jofre
| Phone | 34 93 480 67 10 |
| Web | https://www.reigjofre.com |
Laboratorio Reig Management Efficiency
The company has return on total asset (ROA) of 0.0165 % which means that it generated a profit of $0.0165 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0223 %, meaning that it generated $0.0223 on every $100 dollars invested by stockholders. Laboratorio Reig's management efficiency ratios could be used to measure how well Laboratorio Reig manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Paolo Cionini | Almirall | N/A | |
| Juan Carretero | Pharma Mar SA | 74 | |
| Lara Vadillo | Pharma Mar SA | N/A | |
| Ana Limon | Oryzon Genomics SA | N/A | |
| Fatima Garcia | Laboratorios Farmaceuticos ROVI | N/A | |
| Beatriz Alcalde | Laboratorios Farmaceuticos ROVI | N/A | |
| Ignacio Toledano | Laboratorios Farmaceuticos ROVI | N/A | |
| Francesca Wuttke | Almirall | N/A | |
| Mara Caballero | Pharma Mar SA | N/A | |
| Juan Nogues | Pharma Mar SA | N/A | |
| Rosario Prez | Laboratorios Farmaceuticos ROVI | N/A | |
| Emili Cortada | Oryzon Genomics SA | N/A | |
| Francisco Garca | Laboratorios Farmaceuticos ROVI | N/A | |
| Marcos Pinto | Laboratorios Farmaceuticos ROVI | N/A | |
| Jos MartinezLosa | Pharma Mar SA | N/A | |
| M Perez | Laboratorios Farmaceuticos ROVI | N/A | |
| Fernando Garijo | Laboratorios Farmaceuticos ROVI | N/A | |
| Neus Bernado | Oryzon Genomics SA | N/A | |
| Sonia Bezon | Oryzon Genomics SA | N/A | |
| Sandra Sanchez | Pharma Mar SA | N/A | |
| Saikat Nandi | Oryzon Genomics SA | N/A | |
Management Performance
| Return On Equity | 0.0223 | |||
| Return On Asset | 0.0165 |
Laboratorio Reig Jofre Leadership Team
Elected by the shareholders, the Laboratorio Reig's board of directors comprises two types of representatives: Laboratorio Reig inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Laboratorio. The board's role is to monitor Laboratorio Reig's management team and ensure that shareholders' interests are well served. Laboratorio Reig's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Laboratorio Reig's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nuria Molas, Head Network | ||
| Alejandro Reig, VP Mang | ||
| Victoria Serra, Ma HR | ||
| Antonio Gomez, Managing Spain | ||
| Marc Ramos, Head Consolidation | ||
| Inma SantaPau, Head Relations | ||
| Ignasi Reig, CEO Director | ||
| Estefana Ruiz, Group Controller | ||
| Roser Zabala, Chief Officer | ||
| Ignacio Rocafort, Chief GM |
Laboratorio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Laboratorio Reig a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0223 | |||
| Return On Asset | 0.0165 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 245.01 M | |||
| Shares Outstanding | 76.7 M | |||
| Shares Owned By Insiders | 77.64 % | |||
| Shares Owned By Institutions | 3.46 % | |||
| Price To Earning | 16.69 X | |||
| Price To Book | 0.99 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Laboratorio Reig Jofre. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Laboratorio Reig Jofre information on this page should be used as a complementary analysis to other Laboratorio Reig's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Laboratorio Stock analysis
When running Laboratorio Reig's price analysis, check to measure Laboratorio Reig's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorio Reig is operating at the current time. Most of Laboratorio Reig's value examination focuses on studying past and present price action to predict the probability of Laboratorio Reig's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorio Reig's price. Additionally, you may evaluate how the addition of Laboratorio Reig to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |